• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Atlantic International Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    1/13/25 4:30:25 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $ATLN alert in real time by email
    false 0001605888 0001605888 2025-01-07 2025-01-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported) January 7, 2025

     

    ATLANTIC INTERNATIONAL CORP.

    (Exact name of registrant as specified in charter)

     

    Delaware   001-40760   46-5319744
    (State or other Jurisdiction of
    Incorporation or Organization)
      (Commission File Number)   (IRS Employer
    Identification No.)

     

    270 Sylvan Avenue, Suite 2230

    Englewood Cliffs, NJ

      07632
    (Address of Principal Executive Offices)   (zip code)

     

    (201) 899-4470

    (Registrant’s telephone number, including area code)

     

    NOT APPLICABLE

    (Former name or former address, if changed since last report)

     

    Securities registered or to be registered as pursuant to Section 12(b) of the Act: None

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

     

     

     

     

     

    Item 1.01 Entry Into a Material Definitive Agreement

     

    On January 7, 2024, Atlantic International Corp. (“Atlantic” or the “Company”) entered into a First Amendment (the “Amendment”) to Agreement and Plan of Merger (the “Merger Agreement”), a copy of which has been filed as Exhibit 2.1 to this Form 8-K. The Merger Agreement was entered into as of November 1, 2024 and was filed on Form 8-K on November 7, 2024.

     

    The Amendment provides for:

     

    1. The elimination of dissenters’ rights as the Merger is now a share-for-share exchange and has eliminated the payment by the Company of any cash consideration.

     

    2. The definition of “Merger Consideration” has been revised to include the conversion of Staffing 360 Solutions Inc (“STAF”) Series H Preferred Shares and Series I Preferred Shares into shares of the Company’s Common Stock at their respective Exchange Ratios.

     

    3. The agreement with Jackson Investment Group (“JIG”) shall provide for the conversion of all accrued interest and the principal amount of indebtedness to JIG into 5,600,000 shares of Series I Preferred Stock which is convertible into an equal number of shares of Atlantic Common Stock.

     

    4. The agreements to convert Earned Certain Cash Payments into 5,000,000 shares of Series H Preferred Stock of STAF which, in turn, are converted into 3,500,000 shares of Atlantic Common stock and shall waive any interest/dividends or payments due related solely to Series H Shares.

     

    5. The period of exclusivity for the Merger was deleted.

     

    6. The number of shares of Atlantic Common Stock increased from 50,146,738 to 57,338,135 and the number of restricted stock units increased from 1,803,583 to 4,903,052, or an aggregate of 62,241,187 shares of Common Stock.

     

    7. The Termination Date fee the Merger was extended from December 31, 2024, to March 31, 2025.

     

    8. The definition of Exchange Ratio expanded from1.202 for STAF 360 Common Stock to add 0.25 for Series H Preferred Stock and 1.00 for Series I Preferred Stock.

     

    9. Except as expressly provided in the Amendment, the Merger Agreement remains in full force and effect.

     

    1

     

     

    Forward-Looking Statements Regarding the Merger

     

    This Current Report on Form 8-K, along with the exhibits attached hereto, contains certain “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Exchange Act. All statements other than statements of historical fact contained in this Current Report on Form 8-K, including statements regarding the benefits of the Merger, the anticipated timing of the completion of the Merger, the services offered Atlantic and the markets in which Atlantic plans to operate, the advantages of Atlantic’s services, Atlantic’s competitive landscape and positioning, and Atlantic’s growth plans and strategies, are forward-looking statements. Some of these forward-looking statements can be identified by the use of forward-looking words, including “may,” “should,” “expect,” “intend,” “will,” “estimate,” “anticipate,” “believe,” “predict,” “plan,” “targets,” “projects,” “could,” “would,” “continue,” “forecast” or the negatives of these terms or variations of them or similar expressions. All forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. All forward-looking statements are based upon estimates, forecasts and assumptions that, while considered reasonable by Atlantic and its management, and STAF and its management, as the case may be, are inherently uncertain and many factors may cause the actual results to differ materially from current expectations which include, but are not limited to:

     

    ●the occurrence of any event, change or other circumstance that could give rise to the termination of the Merger;

     

    ●the outcome of any legal proceedings that may be instituted against Atlantic or STAF related to the Merger;

     

    ●failure of Atlantic and STAF to realize the anticipated benefits of the Merger;

     

    ●the risk that the price of shares subsequent to the Merger may be volatile due to a variety of factors, including changes in the highly competitive industry in which Atlantic operates, variations in performance across competitors, changes in laws and regulation that may impose additional costs and compliance burdens on Atlantic’s operations, macro-economic and social environments affecting Atlantic’s business and changes in the combined capital structure; and

     

    ●the inability to implement business plans, forecasts, and other expectations after the completion of the Merger.

     

    Item 9.01 Financial Statements and Exhibits

     

    (d) Exhibits

     

    Exhibit No.   Description
    2.1   First Amendment to Agreement and Plan of Merger dated as of January 7, 2025 by and among Atlantic International Corp, A 36 Merger Sub, Inc. and Staffing 360 Solutions, Inc.
    2.2   Agreement and Plan of Merger dated as of November 1. 2024, by and among Atlantic International Corp, A36 Merger Sub Inc and Staffing 360 Solutions Inc. is incorporated by reference to Exhibit 2.1 to Form 8-K filed by the Registrant on November 7, 2024
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: January 13, 2025 ATLANTIC INTERNATIONAL CORP.
         
      By: /s/ Jeffrey Jagid
        Jeffrey Jagid
        Chief Executive Officer

     

     

    3

     

     

    Get the next $ATLN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATLN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ATLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Atlantic International Appoints Gateway Group to Lead Investor Relations Program

    ENGLEWOOD CLIFFS, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a global provider of outsourced services and workforce solutions, has appointed Gateway Group, a leading strategic corporate and financial communications advisory firm, to lead its investor relations program. Gateway will partner with Atlantic's leadership to strengthen its investor communications strategy and expand engagement within the financial community. The initiative will focus on sharpening the company's messaging and market positioning and expanding outreach to institutional investors and analysts through targeted engagement and conference participation. "Atlantic is entering an

    2/17/26 8:30:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Strengthens Management Team with Appointment of Kevin J. Murphy as Chief Financial Officer

    ENGLEWOOD CLIFFS, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a global provider of staffing and workforce solutions, today announced the appointment of Kevin J. Murphy, CPA, as Chief Financial Officer, effective February 2, 2026, as the Company continues to scale its platform and integrate recent acquisitions. The appointment follows Atlantic International's acquisition of Circle8 Group, a leading European IT and technology staffing firm, creating a diversified global workforce solutions platform with approximately $1.2 billion (unaudited) in annual revenue. The transaction expanded Atlantic's geographic footprint into key European markets and added

    2/2/26 4:05:00 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. Acquires Circle8 Group, Creating a $1.2 Billion Global Workforce Solutions Platform

    ENGLEWOOD CLIFFS, N.J., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a leading provider of strategic staffing and workforce solutions, today announced the acquisition of Circle8 Group. The transaction creates a diversified global workforce solutions platform with $1.2 billion (unaudited) in annual revenue, uniting Atlantic's North American light industrial staffing operations with Circle8's leading European IT and technology talent business. Acquisition Summary Creates a diversified global workforce solutions platform with approximately $1.2 billion (unaudited) in annual revenueExpands Atlantic's geographic footprint into key European marketsAdds high-gro

    1/23/26 8:00:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Financial Officer Broderick Christopher bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 40% to 2,004,237 units (SEC Form 4)

    4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    6/25/25 5:11:34 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: Chief Executive Officer Jagid Jeffrey M bought $289 worth of shares (2,885,856 units at $0.00), increasing direct ownership by 340% to 3,735,169 units (SEC Form 4)

    4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    6/25/25 5:04:40 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: General Counsel Tenore Michael bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 136% to 1,001,634 units (SEC Form 4)

    4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    6/25/25 5:02:59 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Franke Guus Paul Wilhelm claimed ownership of 12,516,070 shares (SEC Form 3)

    3 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    2/10/26 4:05:29 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 3 filed by new insider Murphy Kevin James

    3 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    2/5/26 4:30:02 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Large owner Bressman Andrew exercised 500,000 shares at a strike of $1.33, increasing direct ownership by 8% to 7,003,971 units (SEC Form 4)

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    1/7/26 5:34:58 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    SEC Filings

    View All

    Atlantic International Corp. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    2/3/26 4:36:10 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form EFFECT filed by Atlantic International Corp.

    EFFECT - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    2/2/26 12:15:04 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form POS AM filed by Atlantic International Corp.

    POS AM - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    1/28/26 4:30:13 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    Leadership Updates

    Live Leadership Updates

    View All

    Atlantic International Appoints Gateway Group to Lead Investor Relations Program

    ENGLEWOOD CLIFFS, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a global provider of outsourced services and workforce solutions, has appointed Gateway Group, a leading strategic corporate and financial communications advisory firm, to lead its investor relations program. Gateway will partner with Atlantic's leadership to strengthen its investor communications strategy and expand engagement within the financial community. The initiative will focus on sharpening the company's messaging and market positioning and expanding outreach to institutional investors and analysts through targeted engagement and conference participation. "Atlantic is entering an

    2/17/26 8:30:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Strengthens Management Team with Appointment of Kevin J. Murphy as Chief Financial Officer

    ENGLEWOOD CLIFFS, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a global provider of staffing and workforce solutions, today announced the appointment of Kevin J. Murphy, CPA, as Chief Financial Officer, effective February 2, 2026, as the Company continues to scale its platform and integrate recent acquisitions. The appointment follows Atlantic International's acquisition of Circle8 Group, a leading European IT and technology staffing firm, creating a diversified global workforce solutions platform with approximately $1.2 billion (unaudited) in annual revenue. The transaction expanded Atlantic's geographic footprint into key European markets and added

    2/2/26 4:05:00 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. Appoints Industry Veteran Matt Evelt as Chief Operating Officer to Lead Global Workforce Solutions Strategy

    ENGLEWOOD CLIFFS, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a premier provider of outsourced services, staffing, and workforce solutions, today announced the appointment of Matt Evelt as Chief Operating Officer (COO), effective immediately. Evelt brings more than two decades of leadership experience in workforce strategy, operational transformation, and international expansion. In his new role, he will oversee global operations, drive efficiency, and help scale Atlantic International's delivery of innovative, client-focused staffing and workforce solutions. Evelt most recently served as President – Americas at Airswift, where he successfully led

    6/2/25 1:05:49 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    Financials

    Live finance-specific insights

    View All

    Atlantic International Corp. Acquires Circle8 Group, Creating a $1.2 Billion Global Workforce Solutions Platform

    ENGLEWOOD CLIFFS, N.J., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a leading provider of strategic staffing and workforce solutions, today announced the acquisition of Circle8 Group. The transaction creates a diversified global workforce solutions platform with $1.2 billion (unaudited) in annual revenue, uniting Atlantic's North American light industrial staffing operations with Circle8's leading European IT and technology talent business. Acquisition Summary Creates a diversified global workforce solutions platform with approximately $1.2 billion (unaudited) in annual revenueExpands Atlantic's geographic footprint into key European marketsAdds high-gro

    1/23/26 8:00:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. Reports Strong 2024 Results with Over $442 Million in Revenue; Over 10% Revenue Growth

    Company Completes First Quarter Publicly-Traded on Nasdaq Global Market under "ATLN" Announces Strategic Developments and Outlook; Targets $1 to $1.5 Billion Revenue from Both Organic Growth and M&A Initiatives in the Next 12 to 18 Months ENGLEWOOD CLIFFS, N.J., March 28, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. ("Atlantic" or the "Company") (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services and workforce solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Key Financial Highlights: Q4 2024 Revenue: Revenue for the fourth quarter was $129.5 million, representing an 11.5% increase from $116.

    3/28/25 7:30:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials